News Daily News FDA Clears Dapagliflozin for Heart Failure With Reduced Ejection Fraction Shelley Wood May 06, 2020
News Daily News COVID-19, ACE Inhibitors, and ARBs: Multiple Studies Show No Increased Risk Michael O'Riordan May 05, 2020
News Daily News Smoker’s Paradox Debunked: Post-STEMI Outcomes Worse in Cigarette Smokers Michael O'Riordan April 15, 2020
News Daily News Don’t Overlook COVID-19’s Cardiovascular Footprint, Say NYC Physicians Caitlin E. Cox April 09, 2020
News Conference News ACC 2020 A Win for Vericiguat in High-Risk Chronic HF Patients: VICTORIA Michael O'Riordan March 28, 2020
News Daily News Missed Opportunities: Many HF Patients Not Tested for CAD L.A. McKeown March 20, 2020
News Daily News ACC 2020 Better QoL After MitraClip Plus Fewer Deaths, HF Hospitalizations: COAPT Shelley Wood March 17, 2020
News Daily News LEADER Analysis Reassures on Liraglutide in Diabetic Patients With Heart Failure Shelley Wood March 10, 2020
News Daily News Stick-on Sensor Predicts Heart-Failure Hospitalizations: Pilot Study Shelley Wood February 26, 2020
News Daily News Early CVD Readmissions and Mortality Patterns Differ in Canada and the US Yael L. Maxwell February 18, 2020
News Daily News MitraClip in the US: As Coverage Update Looms, Some Questions for REPAIR MR Shelley Wood January 24, 2020
News Daily News Heart Failure Itself, Not Just the Hospital Stay, May Raise Long-term VTE Risk Caitlin E. Cox January 14, 2020
News Features ‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry Michael O'Riordan January 10, 2020
News Features Year in Review: DAPA-HF Tops Heart Failure News Amid Other Wins and Losses Shelley Wood December 23, 2019
News Daily News Hybrid Approach to Reshaping Left Ventricle Offers Hope for HF Patients L.A. McKeown December 06, 2019
News Conference News AHA 2019 Sex Differences, EF Thresholds Probed for Sacubitril/Valsartan in Heart Failure Shelley Wood November 22, 2019
News Daily News VICTORIA Trial of Vericiguat for Worsening HF Meets Primary Endpoint Todd Neale November 20, 2019
News Conference News AHA 2019 Dapagliflozin Has Benefits Across Heart Failure Subgroups Todd Neale November 17, 2019
News Daily News Inequities Exist in ED Triage of Heart Failure Patients—With Repercussions Caitlin E. Cox October 30, 2019
News Daily News Dapagliflozin Gets Expanded Indication for Prevention of HF Hospitalization in Type 2 Diabetes L.A. McKeown October 21, 2019